EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Type 2 Diabetes and ECOG Performance Status in Colon and Pancreatic Cancer: Exploring the Role of Systemic Inflammation

Zusammenhang zwischen Typ-2-Diabetes und ECOG-Performance-Status bei Kolon- und Pankreaskarzinom: Rolle der systemischen Inflammation

Livia-Mirela Popa, Adrian Boicean, Cristian Ichim, Corina Porr, Oana Stoia, Adriana Popescu, Samuel Bogdan Todor, Paula Anderco

Immuno · 31.10.2026 · 6 (4) · 74

DOI: 10.3390/immuno6040074 ↗

Auf einen Blick

Bei 344 Patient:innen mit Kolon- oder Pankreaskarzinom war Typ-2-Diabetes mit einem schlechteren ECOG-Performance-Status verbunden. Entzündungsmarker waren ebenfalls höher.

Fragestellung

Besteht bei Kolon- und Pankreaskarzinom ein Zusammenhang zwischen Typ-2-Diabetes und dem ECOG-Performance-Status bei Diagnosestellung, und spielt systemische Inflammation eine Rolle?

Methode

Retrospektive Beobachtungsstudie mit 344 Patient:innen; Diagnosen 2019 bis 2025; Analyse zu Diagnosestellung vor onkologischer Behandlung; adjustierte Regressionsmodelle und explorative Mediationsanalyse.

Ergebnisse

T2DM war im ordinalen Modell mit höherem ECOG-PS assoziiert (OR 1,78; 95 %-KI 1,14–2,76; p = 0,010). ECOG 2 vs. 0: OR 2,84; 95 %-KI 1,22–6,63; p = 0,016. CRP 56,4 % und LDH 34,7 % höher.

Einschränkungen

Cross-sectional bei Krebsdiagnose; zeitlicher oder kausaler Schluss durch gleichzeitige Erfassung von Entzündungsmarkern und ECOG-PS nicht möglich; explorative Analyse.

Schlussfolgerung der Autor:innen

In dieser ausgewählten Stichprobe war T2DM bei Diagnosestellung mit einem schlechteren ECOG-Performance-Status und höheren Entzündungsmarkern assoziiert. Die indirekte statistische Assoziation über den Entzündungsscore war explorativ.

Kernaussagen

  • T2DM war mit schlechterem ECOG-PS assoziiert
  • CRP und LDH waren bei T2DM höher
  • Indirekte statistische Assoziation über Entzündungsscore explorativ

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Immuno, online erschienen am 31.10.2026. Verfasst von Livia-Mirela Popa und 7 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is common in patients with gastrointestinal malignancies, yet its relationship with functional status at cancer diagnosis remains poorly defined. Because both diabetes and cancer are characterized by systemic inflammatory activation, inflammation may be associated with the relationship between diabetes and functional impairment.

Methods

We performed a retrospective observational study of 344 patients with colon or pancreatic cancer diagnosed between January 2019 and December 2025, including 172 patients with T2DM and 172 without diabetes, frequency-matched by tumor site. Clinical characteristics, The Eastern Cooperative Oncology Group—ECOG performance status (ECOG-PS) and laboratory parameters were assessed at diagnosis before oncological treatment. Associations between T2DM and ECOG-PS were examined using multinomial and ordinal logistic regression adjusted for age, cancer stage, tumor site, and sex. Multivariable linear regression was used to assess associations with log-transformed C-reactive protein (CRP) and lactate dehydrogenase (LDH). An exploratory analysis evaluated the indirect statistical association through a composite inflammatory score derived from standardized CRP, LDH, and neutrophil count values using 5000 bootstrap samples.

Results

T2DM was independently associated with a higher ECOG-PS category in the ordinal model (OR = 1.78; 95% CI 1.14–2.76; p = 0.010). In the multinomial model, T2DM was associated with ECOG 2 versus ECOG 0 (OR = 2.84; 95% CI 1.22–6.63; p = 0.016), whereas the association with ECOG 1 versus ECOG 0 was not statistically significant. After multivariable adjustment, T2DM was associated with 56.4% higher CRP and 34.7% higher LDH levels. A significant indirect statistical association through the composite inflammatory score was observed (β = 0.147; 95% bootstrap CI 0.083–0.216; p < 0.001), whereas the direct association after inclusion of the inflammatory score was not significant (β = 0.020; 95% CI −0.119 to 0.158; p = 0.780).

Conclusions

In this selected sample assessed cross-sectionally at cancer diagnosis, T2DM was associated with poorer ECOG performance status and higher systemic inflammatory markers. The observed indirect statistical association through the composite inflammatory score should be interpreted as exploratory because the concurrent assessment of inflammatory markers and ECOG-PS precludes temporal or causal inference. Prospective longitudinal studies are required to clarify these relationships.

Zitieren

APA

Popa, L., Boicean, A., Ichim, C., Porr, C., Stoia, O., Popescu, A., Todor, S. B., & Anderco, P. (2026). Association Between Type 2 Diabetes and ECOG Performance Status in Colon and Pancreatic Cancer: Exploring the Role of Systemic Inflammation. Immuno, 6(4), 74. https://doi.org/10.3390/immuno6040074

Vancouver

Popa L, Boicean A, Ichim C, Porr C, Stoia O, Popescu A, et al. Association Between Type 2 Diabetes and ECOG Performance Status in Colon and Pancreatic Cancer: Exploring the Role of Systemic Inflammation. Immuno. 2026;6(4):74. doi:10.3390/immuno6040074

BibTeX
@article{Popa2026,
  author = {Popa, Livia-Mirela and Boicean, Adrian and Ichim, Cristian and Porr, Corina and Stoia, Oana and Popescu, Adriana and Todor, Samuel Bogdan and Anderco, Paula},
  title = {Association Between Type 2 Diabetes and ECOG Performance Status in Colon and Pancreatic Cancer: Exploring the Role of Systemic Inflammation},
  journal = {Immuno},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {74},
  doi = {10.3390/immuno6040074}
}
Kostenlos starten →